Fullspan Health, the B2B healthcare platform from RVO Health, is expanding its marketing offering for 2027 as pharmaceutical and healthcare brands face a more fragmented path between health information discovery, provider engagement and treatment decisions.

The company has introduced a portfolio of marketing solutions spanning consumer and healthcare professional audiences, drawing on brands including Healthline, Healthgrades, Medical News Today, Psych Central and Bezzy. The offerings combine first-party audience data, technology, AI-enabled experiences and editorial content to support marketing programs across different stages of the healthcare journey.

The announcement comes as healthcare marketers contend with several structural challenges, including difficulty accessing providers, misinformation, fragmented health discovery and gaps between the information available to patients and healthcare professionals. Rather than treating consumer and provider marketing as separate channels, Fullspan's approach is increasingly centered on connecting those audiences and measuring movement from information discovery toward action.

Healthcare Marketing Moves Toward Connected Journeys

Healthcare consumers rarely follow a linear path from awareness to care. A person researching a condition may move among search engines, health publishers, social platforms, provider directories and clinical resources before speaking with a healthcare professional.

That fragmentation creates a challenge for pharmaceutical marketers, particularly in categories where education and trust are prerequisites for engagement. It also increases the importance of first-party relationships as third-party identifiers become less reliable and privacy requirements place greater limits on audience targeting.

Fullspan's portfolio is designed around this shift. Its offerings span education, provider engagement, influencer content, email and SMS, AI-assisted discovery and point-of-care marketing.

One of the more notable initiatives is Perspectives 360, which targets both healthcare professionals and consumers in an effort to address communication gaps between the two groups. Practice Forward takes a provider-focused approach, while the Clinically Validated Influencer Network connects pharmaceutical brands with physician creators producing platform-native content.

The strategy reflects a broader movement in healthcare advertising toward combining professional credibility with consumer-oriented digital experiences.

AI Becomes Part of Health Information Discovery

AI is also becoming a more visible component of Fullspan's proposition.

Healthline AI, announced previously, is positioned as a health-specific AI companion intended to provide answers and actionable next steps. The move places Fullspan within a rapidly developing market in which publishers, search companies and healthcare platforms are experimenting with conversational interfaces for health information.

The opportunity comes with significant responsibility. Health information is a high-stakes category where inaccurate or misleading AI-generated answers can have consequences beyond poor user experience. Publisher-backed AI products therefore face pressure to demonstrate sourcing, clinical oversight, transparency and appropriate boundaries around medical guidance.

Fullspan's Reality Check initiative takes a different approach to the information-quality problem. The multimedia program is designed around health misinformation and combines editorial content, social formats, video, events, public relations and an agentic AI experience.

Together, the initiatives show how healthcare media companies are attempting to use AI not only for personalization and efficiency, but also as part of the consumer education and information-verification experience.

From Content to Measurable Action

Other solutions emphasize the transition from information consumption to sustained engagement.

Action Guides use condition-specific content, embedded tools, personalized progression and a four-week newsletter series to encourage users to continue interacting with health information. Daily Dose similarly breaks condition education into short lessons, incorporating gamification and email and SMS engagement.

For marketers, these models address an important limitation of conventional content advertising: an impression or page view provides limited evidence of whether a consumer actually progressed toward an action.

The challenge is measurement. Healthcare marketing requires careful separation between engagement metrics and actual health outcomes, particularly where campaigns involve regulated products, patient data or clinical claims. More connected marketing environments may improve visibility into user journeys, but they also increase the importance of consent, privacy controls and responsible data governance.

Omnichannel SmartMail illustrates this balance. Fullspan says the offering combines digital, physical and point-of-care marketing using privacy-safe, fully opt-in lists matched with high-intent activity from first-party site behavior.

Market Landscape

Fullspan is entering a healthcare advertising market increasingly shaped by first-party data, contextual targeting, connected TV, retail media, provider activation and AI-driven personalization.

Healthcare publishers have an advantage in this environment because established editorial brands can provide recurring first-party audience relationships rather than relying exclusively on external identifiers. However, they also operate under a higher trust burden than many general-interest advertising platforms.

The competitive field includes healthcare publishers, pharmaceutical-focused media networks, provider platforms and large digital advertising ecosystems. Companies such as WebMD, Everyday Health Group and major healthcare data and technology providers compete for pharmaceutical marketing budgets across consumer and professional audiences.

For Fullspan, the strategic differentiator is the combination of multiple established health brands with consumer and HCP audiences. The commercial test will be whether those audiences can be connected without compromising editorial trust, privacy or user experience.

Strategic Outlook

The 2027 portfolio suggests that healthcare marketing is moving beyond channel-specific campaigns toward interconnected ecosystems that combine content, data, technology and measurable engagement.

AI will likely accelerate this transition, particularly as consumers increasingly use conversational interfaces to research health questions. But adoption will depend on whether marketers and publishers can establish credible safeguards around medical accuracy and privacy.

For pharmaceutical brands, the opportunity is to reach consumers and providers at multiple points in the decision journey. The challenge is demonstrating that those connections produce meaningful engagement without turning trusted health environments into overly commercialized experiences.

Fullspan's evolution therefore reflects a broader industry question: Can healthcare media platforms use first-party data and AI to make marketing journeys more connected while preserving the trust that makes those platforms valuable in the first place?

Top Insights

1. Healthcare marketing is becoming journey-based: Fullspan is connecting consumer and provider engagement rather than treating them as isolated audiences.
2. First-party data is central: Privacy-safe audience data is becoming increasingly important as marketers seek alternatives to fragmented targeting signals.
3. AI is entering health discovery: Healthline AI demonstrates the growing role of conversational interfaces in consumer health research.
4. Trust remains a competitive asset: Clinical expertise, editorial oversight and credible creators are becoming increasingly important as health misinformation grows.
5. Measurement is moving beyond impressions: Action-oriented content and omnichannel programs seek to connect engagement with measurable next steps.